Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the recipient of a large drop in short interest in November. As of November 30th, there was short interest totalling 667,800 shares, a drop of 10.7% from the November 15th total of 747,900 shares. Based on an average daily volume of 184,500 shares, the days-to-cover ratio is currently 3.6 days. Approximately 2.1% of the company’s stock are short sold.
Institutional Investors Weigh In On Bioceres Crop Solutions
Several hedge funds and other institutional investors have recently added to or reduced their stakes in BIOX. Oak Family Advisors LLC boosted its stake in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock worth $728,000 after buying an additional 1,208 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after purchasing an additional 5,341 shares in the last quarter. Stifel Financial Corp grew its stake in shares of Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the period. Ping Capital Management Inc. acquired a new position in shares of Bioceres Crop Solutions in the 2nd quarter valued at $448,000. Finally, Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in Bioceres Crop Solutions during the second quarter valued at $472,000. 17.68% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Oppenheimer decreased their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st. Roth Mkm decreased their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Canaccord Genuity Group dropped their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Lake Street Capital decreased their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $12.13.
Bioceres Crop Solutions Stock Performance
Shares of Bioceres Crop Solutions stock traded down $0.13 on Tuesday, reaching $6.64. 42,570 shares of the stock were exchanged, compared to its average volume of 100,107. The business has a 50 day moving average price of $6.84 and a two-hundred day moving average price of $8.98. The firm has a market capitalization of $417.31 million, a price-to-earnings ratio of 338.50 and a beta of 0.51. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. Analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Recommended Stories
- Five stocks we like better than Bioceres Crop Solutions
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What Are Treasury Bonds?
- Salesforce’s Clear Path to $400 and Beyond
- The Basics of Support and Resistance
- HCA Healthcare: 4 Reasons to Buy the 25% Dip
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.